Vaxcyte, Inc. (PCVX)
54.24
-1.24
(-2.24%)
USD |
NASDAQ |
Mar 18, 15:59
54.07
-0.16
(-0.30%)
After-Hours: 18:33
Vaxcyte Total Liabilities (Quarterly) : 360.46M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 84.20B |
| Corcept Therapeutics, Inc. | 190.22M |
| Cytokinetics, Inc. | 2.084B |
| Rhythm Pharmaceuticals, Inc. | 342.12M |
| Sutro Biopharma, Inc. | 296.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.046B |
| Shareholders Equity (Quarterly) | 2.686B |
| Debt to Equity Ratio | 0.0437 |
| Current Ratio | 7.909 |
| Net Debt Paydown Yield | -0.30% |